The Value of lncRNA GHET1 as a Prognostic Factor for Survival of Chinese Cancer Outcome: A Meta-Analysis

Table 1

Summary of the seven included studies.

Study	Origin of population	Study design	Disease		Stage	GHET1 assay	Survival analysis	Metastasis analysis	Hazard ratios	Follow-up (months)
Yang 2013[20]	China	R	GC	42	NA	qRT-PCR	OS	DM/LNM	KM	40
Guan 2017[21]	China	R	NSCLC	52	I/II, III/IV	qRT-PCR	OS	LNM	HR/KM	55
Liu HF 2017[22]	China	R	ESCC	55	I/II, III/IV	qRT-PCR	NA	LNM	NA	NA
Liu H 2017[23]	China	R	HNC	86	I/II, III/IV	qRT-PCR	OS	LNM	KM	70
Zhou 2017[24]	China	R	PC	64	I/II, III/IV	qRT-PCR	NA	DM	NA	NA
Shen 2018[25]	China	R	NSCLC	105	I/II, III/IV	qRT-PCR	OS/PFS	LNM	KM	62
Song 2018[26]	China	R	BC	60	I/II, III/IV	qRT-PCR	OS	LNM	KM	60

DM: distant metastasis; LNM: lymph node metastasis; R: retrospective study; BC: breast cancer; ESCC: esophageal squamous cell carcinoma; GC: gastric cancer; HNC: head and neck cancer; NSCLC: non-small cell lung cancer; PC: pancreatic cancer.